Viral Hepatitis Update: CCO Independent Conference Coverage of EASL 2023 - a podcast by Clinical Care Options

from 2023-07-11T17:33:42

:: ::

In this episode, Stefan Zeuzem, MD, discusses new data on viral hepatitis presented at EASL 2023, including:

Hepatitis B virus
- Durability of response with bepirovirsen
- HBsAg loss with siRNA VIR-2218 combined with either VIR-3434 (novel monoclonal antibody) or pegIFN-alfa
Hepatitis delta virus
- 96-week follow-up of immediate vs delayed bulevirtide
- Off-treatment response for lonafarnib + ritonavir ± pegIFN-alfa
- Safety and efficacy outcomes with siRNA JNJ-3989 + nucleos(t)ide analogue
Hepatitis C virus
- Collaborative service at opiate substitution treatment clinic to improve linkage to care in Ireland
- Nurse-led test-and-treat program to increase screening and diagnosis at female prisons in the United Kingdom
- FIND-C study using machine learning to improve screening-to-diagnosis ratio using clinical factors and social determinants of health

Presenter:

Stefan Zeuzem, MD
Professor of Medicine
Chief, Department of Medicine
JW Goethe University Hospital
Frankfurt, Germany

Link to full program: